TGF-β-induced up-regulation of LOXL2 in tumours, such as hepatocellular carcinoma (HCC), is critical for remodelling ECM components in the tumour microenvironment and metastatic niche [43]. This evidence concerns the gene LOXL2 and hepatocellular carcinoma.